eMedCodes logo

JAKAFI - ruxolitinib

Navigation: NDC > Supplier starting with: I > INCYTE CORPORATION
Field Value
NDC Code: 50881-015
Proprietary Name: JAKAFI
Suffix:
Non-Proprietary Name: ruxolitinib
Dosage Form: TABLET
Method: ORAL
Original Marketing Date: 16-11-2011
Category Name: NDA
Application Number: NDA202192
Labeler: INCYTE CORPORATION
Substance Name: RUXOLITINIB
Active Numerator Strength: 15
Active Ingredient Unit: mg/1
Pharm Classes: Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
DEA Schedule: